AVACTA GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.25 GBX | -0.57% |
|
-4.95% | -62.88% |
| 05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
| 05-01 | Avacta picks Christina Coughlin to replace long-serving CEO | AN |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AVACTA GROUP PLC | Bio Therapeutic Drugs | -0.57% | -4.95% | -62.88% | -61.38% | +55.86% | 195M |  | | |
- Stock Market
- Equities
- AVCT Stock
- Charts Avacta Group Plc
- Relative Strength Chart
